Preventive drugs in the last year of life of older adults with cancer: is there room for deprescribing?
Background The continuation of preventive drugs among older patients with advanced
cancer has come under scrutiny because these drugs are unlikely to achieve their clinical …
cancer has come under scrutiny because these drugs are unlikely to achieve their clinical …
Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?
L Morin, A Todd, S Barclay, JW Wastesson… - Cancer, 2019 - pubmed.ncbi.nlm.nih.gov
Background The continuation of preventive drugs among older patients with advanced
cancer has come under scrutiny because these drugs are unlikely to achieve their clinical …
cancer has come under scrutiny because these drugs are unlikely to achieve their clinical …
Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?
AT Lucas Morin, S Barclay, JW Wastesson, J Fastbom… - Cancer, 2019 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background</jats: title>< jats: p> The continuation of preventive
drugs among older patients with advanced cancer has come under scrutiny because these …
drugs among older patients with advanced cancer has come under scrutiny because these …
[引用][C] Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?
L Morin, A Todd, S Barclay, JW Wastesson, J Fastbom… - Cancer, 2019 - eprints.ncl.ac.uk
Background: The continuation of preventive drugs for older patients with advanced cancer
has come under scrutiny since these drugs are unlikely to achieve their clinical benefit …
has come under scrutiny since these drugs are unlikely to achieve their clinical benefit …
Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?
L Morin, A Todd, S Barclay, JW Wastesson, J Fastbom… - 2019 - repository.cam.ac.uk
BACKGROUND: The continuation of preventive drugs among older patients with advanced
cancer has come under scrutiny because these drugs are unlikely to achieve their clinical …
cancer has come under scrutiny because these drugs are unlikely to achieve their clinical …
[PDF][PDF] Preventive drugs in the last year of life of older adults with cancer: is there room for deprescribing?
core.ac.uk
Preventive drugs in the last year of life of older adults with cancer: is there room for
deprescribing? Page 1 Preventive drugs in the last year of life of older adults with cancer: is there …
deprescribing? Page 1 Preventive drugs in the last year of life of older adults with cancer: is there …
Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?
L Morin, A Todd, S Barclay, JW Wastesson, J Fastbom… - Cancer, 2019 - diva-portal.org
Background The continuation of preventive drugs among older patients with advanced
cancer has come under scrutiny because these drugs are unlikely to achieve their clinical …
cancer has come under scrutiny because these drugs are unlikely to achieve their clinical …
Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?
L Morin, A Todd, S Barclay, JW Wastesson, J Fastbom… - Cancer, 2019 - europepmc.org
Background The continuation of preventive drugs among older patients with advanced
cancer has come under scrutiny because these drugs are unlikely to achieve their clinical …
cancer has come under scrutiny because these drugs are unlikely to achieve their clinical …